Karyopharm Therapeutics Inc. (KPTI)
NASDAQ: KPTI · Real-Time Price · USD
2.000
+0.070 (3.63%)
At close: Aug 19, 2026, 4:00 PM EDT
1.990
-0.010 (-0.50%)
After-hours: Aug 19, 2026, 7:35 PM EDT

Karyopharm Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
54.9860.5462.4852.23135.19190.46
Short-Term Investments
10.133.246.24139.21142.7838.16
Cash & Short-Term Investments
65.1163.74108.71191.44277.97228.62
Cash Growth
25.94%-41.36%-43.21%-31.13%21.59%-8.28%
Receivables
29.8726.1830.7727.9654.8923.9
Inventory
3.994.044.743.044.224.11
Prepaid Expenses
7.419.1912.2510.8112.0212.64
Restricted Cash
---0.661.066.35
Total Current Assets
106.38103.15156.46233.92350.16275.61
Property, Plant & Equipment
4.354.656.284.887.389.56
Long-Term Accounts Receivable
-----19.51
Other Long-Term Assets
0.590.621.671.640.630.64
Total Assets
111.32108.42164.42240.44358.17305.31
Accounts Payable
7.6645.113.122.771.6
Accrued Expenses
78.864.560.6561.3958.4269.12
Short-Term Debt
--24.43---
Current Portion of Long-Term Debt
40.3121.01----
Current Portion of Leases
1.070.970.443.312.872.32
Other Current Liabilities
6.391.581.641.651.850.68
Total Current Liabilities
134.2392.0692.2669.4865.9173.72
Long-Term Debt
281.97278.22236.45303.4302.82302.29
Long-Term Leases
5.185.746.712.796.18.97
Other Long-Term Liabilities
20.125.3215.010.98--
Total Liabilities
441.49401.34350.44376.64374.83384.98
Common Stock
0.010.010.010.010.010.01
Additional Paid-In Capital
1,5191,4661,3781,3511,3281,099
Retained Earnings
-1,849-1,759-1,563-1,487-1,344-1,179
Comprehensive Income & Other
0.040.07-0.36-0.16-0.640.19
Shareholders' Equity
-330.17-292.93-186.02-136.21-16.66-79.67
Total Liabilities & Equity
111.32108.42164.42240.44358.17305.31
Total Debt
328.53305.95268.02309.5311.79313.58
Net Cash (Debt)
-263.43-242.2-159.31-118.05-33.83-84.96
Net Cash Growth
------
Net Cash Per Share
-13.57-22.15-18.84-15.50-6.20-16.94
Filing Date Shares Outstanding
22.6818.348.427.677.565.28
Total Common Shares Outstanding
22.6818.318.417.667.555.05
Working Capital
-27.8611.0964.2164.44284.25201.89
Book Value Per Share
-14.56-16.00-22.11-17.78-2.21-15.78
Tangible Book Value
-330.17-292.93-186.02-136.21-16.66-79.67
Tangible Book Value Per Share
-14.56-16.00-22.11-17.78-2.21-15.78
Machinery
-2.212.212.292.332.25
Leasehold Improvements
-3.44.884.885.455.45
SEC Filings: 10-K · 10-Q